FDA Approved: ISENTRESS — Original Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

FDA approval of Isentress (raltegravir) through the original application for the treatment of HIV-1 infection in combination with other antiretroviral agents.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Isentress (Raltegravir)

Snippet

ORIG AP for ISENTRESS (RALTEGRAVIR)